Melo SA et al.
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell (2014) 26:707-21. Highly Cited (1100+) exRNA and EV Biology EV Biology
Sercombe L et al.
Advances and challenges of liposome assisted drug delivery. Front Pharmacol (2015) 6:286. Highly Cited (950+) Therapeutics
Akers JC et al.
Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol (2013) 113:1-11. Highly Cited (750+) Review exRNA and EV Biology EV Biology
Lener T et al.
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J Extracell Vesicles (2015) 4:30087. Highly Cited (600+) Review Therapeutics
Keerthikumar S et al.
ExoCarta: A web-based compendium of exosomal cargo. J Mol Biol (2016) 428:688-692. Highly Cited (550+) Resources and Technology
Abels ER & Breakefield XO.
Introduction to extracellular vesicles: Biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol (2016) 36:301-12. Highly Cited (550+) Review exRNA and EV Biology EV Biology
Bahn JH et al.
The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem (2015) 61:221-30. Highly Cited (450+) Resources and Technology
Khvorova A & Watts JK.
The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol (2017) 35:238-248. Highly Cited (400+)
Slenter DN et al.
WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res (2018) 46:D661-D667. Highly Cited (400+) Resources and Technology
Lai CP et al.
Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano (2014) 8:483-94. Highly Cited (400+) exRNA and EV Biology EV Biology Resources and Technology
Berindan-Neagoe I et al.
MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin (2014) 64:311-36. Highly Cited (350+)
Mateescu B et al.
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles (2017) 6:1286095. Highly Cited (350+) Review Resources and Technology
Byron SA et al.
Translating RNA sequencing into clinical diagnostics: Opportunities and challenges. Nat Rev Genet (2016) 17:257-71. Related blog post Highly Cited (350+) Review Biomarkers
Shao H et al.
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun (2015) 6:6999. Highly Cited (350+) Resources and Technology
Gyorgy B et al.
Therapeutic applications of extracellular vesicles: Clinical promise and open questions. Annu Rev Pharmacol Toxicol (2015) 55:439-64. Highly Cited (300+) Review Therapeutics
Boettcher M & McManus MT.
Choosing the right tool for the job: RNAi, TALEN, or CRISPR. Mol Cell (2015) 58:575-85. Highly Cited (300+)
Pecot CV et al.
Tumour angiogenesis regulation by the miR-200 family. Nat Commun (2013) 4:2427. Highly Cited (300+)
Krzeszinski JY et al.
MiR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature (2014) 512:431-5. Highly Cited (300+) exRNA Biology Therapeutics Related Pathway
Sung BH et al.
Directional cell movement through tissues is controlled by exosome secretion. Nat Commun (2015) 6:7164. Highly Cited (300+) exRNA and EV Biology EV Biology
Vader P, Breakefield XO & Wood MJ.
Extracellular vesicles: Emerging targets for cancer therapy. Trends Mol Med (2014) 20:385-393. Highly Cited (250+) Review Therapeutics